Latest Market Challenges News

Finder Energy has locked in a significant funding agreement with TIMOR GAP, securing half of the KTJ Project’s development capex and upgrading its resource base, setting the stage for a Final Investment Decision by mid-2026.

IGO Limited reports improved safety metrics and steady production despite operational headwinds, maintaining a strong balance sheet and positive cash flow.

Volt Resources has secured strategic funding and relocated its US operations to Alabama, advancing its graphite refinery ambitions while winning a key legal battle in Ukraine.

Cann Group Limited reported a near break-even net operating cash flow for Q1 FY2026 and achieved its first EBITDA-positive month, setting the stage for a major debt restructure that will significantly reduce its borrowings.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Challenger Limited has welcomed APRA’s proposed capital standards for longevity products, highlighting their potential to reduce capital requirements and stimulate growth in Australia’s retirement income sector.

Locate Technologies reports a 19% revenue increase in its Locate2u segment and progresses toward a December 2025 NZX listing, supported by new board appointments and a NZD 10 million ATM facility.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.

SOCO Corporation Ltd has reported a return to profitability in FY25, driven by revenue growth and strategic investments. The company is now focused on disciplined execution and client diversification to sustain momentum into FY26.

Bathurst Resources reported a Q1 FY26 EBITDA of NZD 5.2 million, maintaining full-year guidance and progressing major development projects in New Zealand and Canada.

Optiscan Imaging Ltd secured $17.75 million in a fully underwritten equity raise, fueling clinical studies and regulatory preparations for its innovative medical imaging devices. The company also reported progress in international trials and strengthened its cash position to nearly $20 million.

Liontown Resources reported a robust September quarter, doubling underground ore output and strengthening its balance sheet to $420 million. The company’s FY26 guidance confirms a strategic shift to underground mining with anticipated cost improvements.